SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-11-310122
Filing Date
2011-11-14
Accepted
2011-11-14 13:20:41
Documents
11
Period of Report
2011-09-30
Filing Date Changed
2011-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d244508d10q.htm 10-Q 572257
2 THIRD LOAN MODIFICATION AGREEMENT d244508dex101.htm EX-10.1 30235
3 SECTION 302 CERT OF CEO d244508dex311.htm EX-31.1 6051
4 SECTION 302 CERT OF CFO d244508dex312.htm EX-31.2 6055
5 SECTION 906 CERTIFICATION d244508dex321.htm EX-32.1 7033
  Complete submission text file 0001193125-11-310122.txt   2031663

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ecyt-20110930.xml EX-101.INS 226694
7 XBRL TAXONOMY EXTENSION SCHEMA ecyt-20110930.xsd EX-101.SCH 12092
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ecyt-20110930_cal.xml EX-101.CAL 31168
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ecyt-20110930_def.xml EX-101.DEF 15818
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ecyt-20110930_lab.xml EX-101.LAB 127470
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ecyt-20110930_pre.xml EX-101.PRE 79384
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 111200356
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1